Tag
This newsletter from MIT Technology Review covers the debate on AI extinction risks with a roundtable event and highlights Yuancheng Lu's age-reversal genetic therapy for restoring vision that has entered human clinical trials.
The article explores a report on AI bioweapons, highlighting the division among experts regarding the validity of the warnings and whether they represent a genuine threat or an overreaction.
Scientists have accidentally created a synthetic cell factory, which could advance biotechnology and medical applications.
The article reports on the advancement of chemogenetics (DREADDs) into human clinical trials in China for treating neurological disorders, highlighting new therapeutic possibilities for brain control.
Engineered yeast consortia are designed to convert plastic and biomass-derived compounds into valuable food additives, promoting sustainability and innovation in food production.
A tweet from @rand_longevity questions whether aging should be classified as a disease, sparking discussion in longevity and health communities.
Michael Polansky, co-founder of Outer Biosciences, discusses training an AI model on living human skin tissue that can survive outside the body for over a month.
A tweet discussing the stock chart of a company that has reportedly cured cancer.
Anthropic AI announced that Claude successfully designed novel protein binders for 14 out of 15 drug targets, with independent verification by Adaptyv Bio and Twist Bioscience.
This research report presents a U.S. strategy to prevent the creation of mirror life, a hypothetical form of life with reversed chirality that could cause irreversible biological disruption and global catastrophic risks.
An MIT Technology Review article explores the various uses of cloning, from conservation efforts to pet cloning and potential human applications, noting both its benefits and ethical concerns.
DeepSCan is a new AI model that learns the rules of cell-surface display and generates novel membrane display modules, several outperforming strong natural sequences, marking a step toward programmable cellular engineering.
A research paper highlights a major AI-driven breakthrough in synthetic biology and green chemistry, as reported by Nature Communications.
Montana's new right-to-try law offers hope to families like Kris DeVault's, whose son Brody has a rare genetic condition that an experimental, unapproved drug might help treat.
An AI tool called Raygun can scale natural proteins up or down without disrupting their structure or function, potentially advancing protein engineering.
This edition of The Download covers laser enrichment for nuclear fuel and organ preservation advances, along with other tech news including Silicon Valley's split over Chinese AI.
This Nature research paper presents an AI method that redesigns starting points and outcomes to enhance protein evolution.
Researchers have successfully supercooled pig kidneys for days and transplanted them, a landmark achievement that brings organ banking closer to reality.
University of Nottingham researchers developed a protein-based gel that promotes organized regrowth of tooth enamel, potentially revolutionizing cavity prevention and treatment of sensitive teeth, as published in Nature Communications.
Researchers at the Technical University of Denmark used a hybrid AI and quantum computing approach to generate novel peptides that bind to specific proteins, showing improved performance especially with sparse data, potentially accelerating vaccine and personalized immunotherapy development.